Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis

Ticker
GERN

Price
1.41
Stock movement up
+0.07 (5.24%)
Company name
Geron Corporation
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
896.89M
Ent value
1.14B
Price/Sales
4.89
Price/Book
3.61
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-5.60%
1 year return (CAGR)
-52.53%
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Last updated: 2026-01-22

iO Charts is a Seeking Alpha partner

DIVIDENDS

GERN does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales4.89
Price to Book3.61
EV to Sales6.20

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count638.36M
EPS (TTM)-0.12
FCF per share (TTM)-0.20

Income statement

Loading...
Income statement data
Revenue (TTM)183.40M
Gross profit (TTM)158.11M
Operating income (TTM)-63.09M
Net income (TTM)-79.99M
EPS (TTM)-0.12
EPS (1y forward)-0.02

Margins

Loading...
Margins data
Gross margin (TTM)86.21%
Operating margin (TTM)-34.40%
Profit margin (TTM)-43.61%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash78.12M
Net receivables35.36M
Total current assets522.34M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment3.31M
Total assets567.38M
Accounts payable11.11M
Short/Current long term debt121.92M
Total current liabilities87.71M
Total liabilities318.68M
Shareholder's equity248.71M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-132.91M
Capital expenditures (TTM)368.00K
Free cash flow (TTM)-133.28M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-32.16%
Return on Assets-14.10%
Return on Invested Capital-21.68%
Cash Return on Invested Capital-36.12%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open1.33
Daily high1.41
Daily low1.32
Daily Volume11.5M
All-time high65.99
1y analyst estimate3.60
Beta0.57
EPS (TTM)-0.12
Dividend per share0.00
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
GERNS&P500
Current price drop from All-time high-97.87%-0.89%
Highest price drop-98.38%-19.00%
Date of highest drop7 Nov 20258 Apr 2025
Avg drop from high-96.95%-2.49%
Avg time to new high-6 days
Max time to new high322 days89 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
GERN (Geron Corporation) company logo
Marketcap
896.89M
Marketcap category
Small-cap
Description
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.
Employees
229
Investor relations
-
SEC filings
CEO
John A. Scarlett
Country
USA
City
Menlo Park
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...